New Egyptian Journal of Medicine [The]. 2007; 37 (6 Supp.): 73-79
en Inglés
| IMEMR
| ID: emr-187291
ABSTRACT
Hepatic ischemia/reperfusion [I/R] injury is the main cause of hepatic damage and is inevitable after hepatic surgery, liver transplantation, shock, trauma. Despite the recent improvements in liver preservation and surgical techniques, hepatic I/R injury remains an important clinical complication. To control this complicated physiological as well as pathological process, further studies are required to find out the key pathway and a novel therapeutic approach. PPAR gamma may be a protective regulator against ischemic damage. The aim of this study is to study the effect of pioglitazone on hepatic ischemic-reperfusion injury and compare its effect with ischemic preconditioning
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Ratas
/
Sustancias Protectoras
/
Tiazolidinedionas
/
Antioxidantes
Límite:
Animales
Idioma:
Inglés
Revista:
New Egypt. J. Med.
Año:
2007
Similares
MEDLINE
...
LILACS
LIS